NEWS: Migal Galilee Research Institute Uses Dassault Systèmes’ BIOVIA Applications in Its COVID-19 Vaccine R&D

image > Dassault Systèmes

As the life sciences ecosystem races to contain and fight the COVID-19 outbreak, scientists at the Migal Galilee Research Institute in Israel are using Dassault Systèmes’ BIOVIA applications to accelerate their research and development of a possible vaccine against SARS-CoV-2.

Migal had been using BIOVIA applications in addition to an array of computational tools for four years of multidisciplinary research on avian coronavirus vaccine development projects.  When COVID-19 became a pandemic, this academic research and development center – which focuses on plant science, agriculture, environmental science, computer science, nutrition and biotechnology – began using these applications and computational tools to apply its research to the study of COVID-19 mutations, with a view to deliver a novel coronavirus vaccine for humans for in vivo pre-clinical testing within 90 days.   

In the context of COVID-19, Dassault Systèmes’ 3DEXPERIENCE platform and digital applications can help the healthcare ecosystem address research and clinical development, manufacturing and patient care.  

By using BIOVIA for its COVID-19 R&D, Migal Galilee Research Institute can guide its laboratory and experiment management processes with a digital approach that speeds research results. Its scientists can quickly process and analyze the research data gathered during the past four years and model viral protein behavior and the evolution of its predicted neutralization epitopes. This enables them to rationalize the test results from different aspects of their past research and decide which research strategies to take going forward.

BIOVIA Pipeline Pilot streamlines the research innovation cycle by supporting the rapid development and deployment of data science workflows that accelerate the generation of actionable scientific insights. BIOVIA Discovery Studio delivers a comprehensive set of modeling and simulation methods to explore the nuances of protein chemistry and drive the discovery and development of small and large molecule therapeutics from target ID to lead optimization.

For more information:

Original news publication - Dassault Systemes Newsroom

Date - 22nd June, 2020

Share this:

A profile picture for

22nd June


Latest Jobs

Architect, Windchill PLM

West Chester, PA, USA Competitive Permanent

Posted on behalf of

Johnson & Johnson

About the job Job DescriptionJohnson & Johnson Technology (JJT), the Enterprise Technology group supporting all business functions under Johnson & Johnson is currently recruiting for an Architect,...

PLM Analyst

Manhattan Beach, CA, USA Competitive Permanent

Posted on behalf of


About the job Description: Company Overview Fisker Inc. is a design led pioneering mobility technology company researching, developing and producing next generation electrically power...

Application Consultant - Data Management Solutions

Quakertown, PA, USA Competitive Permanent

Posted on behalf of

Synergis Engineering Design Solutions

About the job Synergis Technologies, the region’s leader in data management, engineering, architectural, civil and manufacturing design solutions is searching for an engineering professional who is...

Looking for people to join your team?

Advertise your role with Momentum PLM. Get Started 

Looking to become a contributor?

Submit an article to Momentum PLM.  Get Involved 

Our Contributors

See the minds behind Momentum PLM.  Learn More 

Meet the Vendors

Read up on the latest vendor updates  Learn More 

Get the latest PLM updates in your inbox

Subscribe to our newsletter

Email Address


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

By submitting your email address and any other personal information on the website, you consent to it being collected, held, used and disclosed in accordance with our Privacy Policy.